These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1710744)

  • 41. Hyperlipidaemia of diabetes.
    Gibbons GF
    Clin Sci (Lond); 1986 Nov; 71(5):477-86. PubMed ID: 3533393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A community study of high density lipoproteins in adult noninsulin-dependent diabetics.
    Barrett-Connor E; Witztum JL; Holdbrook M
    Am J Epidemiol; 1983 Feb; 117(2):186-92. PubMed ID: 6829548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Lipoprotein abnormalities in normolipidemic diabetics].
    Yoshino G; Hirano T; Kazumi T
    Nihon Rinsho; 1997 Oct; 55 Suppl():609-19. PubMed ID: 9392170
    [No Abstract]   [Full Text] [Related]  

  • 44. [Changes in lipoprotein metabolism caused by diabetic serum factors (DS) in fibroblasts of diabetics and metabolically normal patients].
    Koschinsky T; Bünting CE; Schwippert B
    Verh Dtsch Ges Inn Med; 1978; (84):1147-51. PubMed ID: 741912
    [No Abstract]   [Full Text] [Related]  

  • 45. Abnormalities of lipid metabolism and methods of their correction in patients with glomerulonephritis.
    Pyrig LA; Melman NYa ; Petrun NM; Nikulina GG; Gorelova NR
    Int Urol Nephrol; 1984; 16(4):361-7. PubMed ID: 6535784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diabetes and atherosclerosis. Metabolic links.
    Steiner G
    Drugs; 1988; 36 Suppl 3():22-6. PubMed ID: 3076116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An antibody to low density lipoprotein in diabetics.
    Wardle EN
    Experientia; 1978 Jul; 34(7):886-7. PubMed ID: 208857
    [No Abstract]   [Full Text] [Related]  

  • 48. Screening for hyperlipidaemia in diabetics.
    al-Jubouri MA; Young RM
    Ann Clin Biochem; 1992 Sep; 29 ( Pt 5)():572. PubMed ID: 1444175
    [No Abstract]   [Full Text] [Related]  

  • 49. Breakthrough could ease life for diabetics.
    Nurs Stand; 1990 Jan; 4(18):10. PubMed ID: 27237889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of various lipid-lowering treatments in diabetics.
    Steiner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 9():S35-9. PubMed ID: 1710744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in drug treatment of dyslipidemia: focus on atorvastatin.
    Davignon J
    Can J Cardiol; 1998 May; 14 Suppl B():28B-38B. PubMed ID: 9627539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.